Kyle Rose
Stock Analyst at Canaccord Genuity
(2.60)
# 1,921
Out of 5,182 analysts
112
Total ratings
51.61%
Success rate
12.92%
Average return
Main Sectors:
Stocks Rated by Kyle Rose
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| PODD Insulet | Maintains: Buy | $432 → $450 | $182.87 | +146.08% | 17 | Dec 17, 2025 | |
| SNN Smith & Nephew | Maintains: Hold | $27 | $31.08 | -13.13% | 6 | Feb 26, 2025 | |
| SYK Stryker | Maintains: Buy | $420 → $435 | $321.43 | +35.33% | 20 | Jan 29, 2025 | |
| GMED Globus Medical | Maintains: Buy | $67 → $71 | $90.74 | -21.75% | 7 | Dec 20, 2023 | |
| ENOV Enovis | Maintains: Buy | $65 → $71 | $23.40 | +203.42% | 3 | Dec 20, 2023 | |
| INMD InMode | Downgrades: Hold | $55 → $22 | $14.21 | +54.82% | 10 | Oct 13, 2023 | |
| SKIN SkinHealth Systems | Assumes: Buy | $10 | $0.84 | +1,096.89% | 4 | Aug 25, 2023 | |
| ATEC Alphatec Holdings | Maintains: Buy | $17 → $22 | $9.35 | +135.29% | 4 | Aug 4, 2023 | |
| DXCM DexCom | Maintains: Buy | $135 → $150 | $59.32 | +152.87% | 17 | Jul 28, 2023 | |
| SIBN SI-BONE | Maintains: Buy | $24 → $27 | $12.36 | +118.45% | 3 | May 2, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $15 | $0.78 | +1,823.08% | 1 | Mar 28, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $15 | $41.99 | -64.28% | 6 | Mar 28, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Market Perform | $125 → $122 | $156.30 | -21.94% | 1 | Mar 1, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgrades: Buy | $3 → $4 | $4.08 | -1.96% | 4 | Nov 10, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Hold | n/a | $9.95 | - | 2 | Nov 9, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Hold | $165 → $125 | $82.80 | +50.97% | 7 | Feb 8, 2022 |
Insulet
Dec 17, 2025
Maintains: Buy
Price Target: $432 → $450
Current: $182.87
Upside: +146.08%
Smith & Nephew
Feb 26, 2025
Maintains: Hold
Price Target: $27
Current: $31.08
Upside: -13.13%
Stryker
Jan 29, 2025
Maintains: Buy
Price Target: $420 → $435
Current: $321.43
Upside: +35.33%
Globus Medical
Dec 20, 2023
Maintains: Buy
Price Target: $67 → $71
Current: $90.74
Upside: -21.75%
Enovis
Dec 20, 2023
Maintains: Buy
Price Target: $65 → $71
Current: $23.40
Upside: +203.42%
InMode
Oct 13, 2023
Downgrades: Hold
Price Target: $55 → $22
Current: $14.21
Upside: +54.82%
SkinHealth Systems
Aug 25, 2023
Assumes: Buy
Price Target: $10
Current: $0.84
Upside: +1,096.89%
Alphatec Holdings
Aug 4, 2023
Maintains: Buy
Price Target: $17 → $22
Current: $9.35
Upside: +135.29%
DexCom
Jul 28, 2023
Maintains: Buy
Price Target: $135 → $150
Current: $59.32
Upside: +152.87%
SI-BONE
May 2, 2023
Maintains: Buy
Price Target: $24 → $27
Current: $12.36
Upside: +118.45%
Mar 28, 2023
Reiterates: Buy
Price Target: $15
Current: $0.78
Upside: +1,823.08%
Mar 28, 2023
Reiterates: Buy
Price Target: $15
Current: $41.99
Upside: -64.28%
Mar 1, 2023
Maintains: Market Perform
Price Target: $125 → $122
Current: $156.30
Upside: -21.94%
Nov 10, 2022
Upgrades: Buy
Price Target: $3 → $4
Current: $4.08
Upside: -1.96%
Nov 9, 2022
Downgrades: Hold
Price Target: n/a
Current: $9.95
Upside: -
Feb 8, 2022
Downgrades: Hold
Price Target: $165 → $125
Current: $82.80
Upside: +50.97%